Skip to main content

Peer Review reports

From: The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma

Original Submission
1 Dec 2023 Submitted Original manuscript
11 Dec 2023 Reviewed Reviewer Report - Tanan Bejrananda
17 Dec 2023 Reviewed Reviewer Report
27 Dec 2023 Author responded Author comments - Haitao Zhu
Resubmission - Version 2
27 Dec 2023 Submitted Manuscript version 2
28 Dec 2023 Reviewed Reviewer Report - Tanan Bejrananda
29 Dec 2023 Reviewed Reviewer Report
8 Jan 2024 Author responded Author comments - Haitao Zhu
Resubmission - Version 3
8 Jan 2024 Submitted Manuscript version 3
12 Jan 2024 Reviewed Reviewer Report
14 Jan 2024 Reviewed Reviewer Report - Tanan Bejrananda
17 Jan 2024 Author responded Author comments - Haitao Zhu
Resubmission - Version 4
17 Jan 2024 Submitted Manuscript version 4
22 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report - Tanan Bejrananda
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
24 Jan 2024 Editorially accepted
13 Feb 2024 Article published 10.1186/s12885-024-11919-1

You can find further information about peer review here.

Back to article page